CLICK BUTTON TO GET TO THE SIGN-ON LETTER
- US continues to keep India on intellectual property priority watch list
- On IP Protection, USTR Finds Fault With China, India … And Switzerland?
- US Special 301 inconsistent with WTO rules, says India
- Member of Parliament concerned on IPR discussions in RCEP can impact access to medicines
- ‘Secretive’ patent talks is worrying generic drug activists